Biotech Business Week articles from March 2003

Biotech Business Week archives from March 2003

Pharmaceutical thought leader study: Local opinion underused.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Regional and national thought leaders are involved in 79% of key pharmaceutical marketing activities, according to a new study by pharmaceutical intelligence firm Cutting Edge Information. Compared...

Study looks at what drives satisfaction in the life-science market.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Biological scientists expressed a high degree of satisfaction with the technologies and suppliers who support their research. These same scientists tend to perceive their primary suppliers to be...

Pharmaceutical and biotech companies collaborate to increase revenue and pipelines.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Pharmaceutical companies must double the current number of new chemical entities they develop to meet Wall Street analysts' growth expectations. Rapid sales growth for blockbuster products forces...

Report: Pharmaceutical companies can improve health outcomes.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- The inability to understand information about prescription medications contributes to poor health outcomes, according to 75% of recently surveyed patients, physicians, and pharmacists. In fact, for...

Two biotech companies propose merger.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- The Boards of Cambridge Antibody Technology Group plc (CAT) and Oxford Glycosciences plc (OGS) announced that the documents relating to the recommended merger of CAT and OGS were posted to shareholders...

Cell therapy poised for change and growth.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Drug & Market Development (D&MD) predicts the cell therapy market will reach $30 billion by 2010. D&MD's report, "Cell Therapy: Technology, Markets & Opportunities," describes the strategies and...

Information technology firm names new chief science officer.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Accelrys, a wholly owned subsidiary of Pharmacopeia, Inc. (NASDAQ:PCOP), announced the appointment of Dr. Scott Kahn as the chief science officer of Accelrys' worldwide operations. Under Dr. Kahn's...

Company specializing in gene therapy reports year-end financial results.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Avigen, Inc. (NASDAQ:AVGN), a specialist in adeno-associated virus gene delivery technology, reported financial results for the year ended December 31, 2002. At year end, Avigen had $120 million in...

Drug discovery partner announces fourth quarter 2002 financial results.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Aclara BioSciences (NASDAQ:ACLA) has reported financial results for the three months and year ended December 31, 2002. Revenues for the three months ended December 31, 2002, were $752,000, compared...

Imaging technology firm announces first quarter results.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- CTI Molecular Imaging, Inc. (NASDAQ:CTMI), a provider of positron emission tomography (PET) equipment, molecular probes, and services, announced financial results for its fiscal first quarter ended...

Orthopedic implant firm reports 2002 sales from continuing operations rise 7%.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Centerpulse (NYSE: CEP; Swiss Stock Market symbol: CEPN) reported total sales for continuing operations in 2002 of CHF 1,240.7 million, an increase of 7.0% over 2001. When adjusted for negative...

Company launches new corporate identity, emphasizes quality.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- ABR-Affinity BioReagents, Inc., has announced the launch of its new corporate identity. The direct result of candid customer suggestions and input, this new identity encompasses the use of a new...

Micro Therapeutics receives $7.7 million milestone payment.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Micro Therapeutics, Inc., (MTIX) has received a $7.7 million milestone payment as part of the previously announced acquisition, by Boston Scientific Corp. (BSX), of Enteric Medical Technologies, Inc.,...

Mary Callan, PhD, named vice president, business development.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Morphotek, Inc., announced the appointment of Mary Callan, PhD, to the position of vice president of business development. Prior to joining Morphotek, Callan was director of business development at...

Patents awarded for densitometer.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- Alara, Inc., announced that two patents (U.S. Patents No. 6,490,339 and No. 6,510,197) were issued for its MetriScan peripheral bone densitometer. The MetriScan, a self-contained, table-top device,...

Biotechnology group taps Dr. Paul Kornblith to lead Pittsburgh office.
March 3, 2003... 2003 MAR 3 - (NewsRx.com & NewsRx.net) -- The Pennsylvania Biotechnology Association (PABIOTECH) has announced the appointment of a new regional director of business development. Dr. Paul Kornblith, a neurosurgeon, researcher, and...

Launching blockbuster drugs: Postlaunch marketing resources rising.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Postlaunch marketing accounts for 34% of the total marketing spent once a new pharmaceutical product hits the market, according to a new study by pharmaceutical intelligence firm Cutting Edge...

Early replacement of units propels growth in ambulatory telemetry markets.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Early replacement of telemetry units by hospitals, clinics, and rehabilitation facilities will drive rapid growth of the hospital ambulatory telemetry monitoring equipment markets in the United States...

Electronic health's influence continues to grow.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- The state of online healthcare is alive and well, according to The Boston Consulting Group's new report, "Vital Signs: E-Health in the United States." In fact, e-health is growing more pervasive...

Demand for travel nurses expected to increase in 2003.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Helping healthcare facilities maintain appropriate staffing levels, q Shift Travel Nurses, announced that recent business developments suggest that the demand for travel nurses is going to increase in...

Demand for integrated healthcare systems spurs market.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- The increasing need for fully integrated machines in healthcare facilities is the primary growth catalyst for anesthesia and respiratory products in the United States. However, competing...

Agreement with Hong Kong company involves use of Gradiflow Technology.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Gradipore (GDP) announced an agreement with Advantek Biologics Limited of Hong Kong, China, for a three-stage application of the company's Gradiflow separations technology for use in intravenous...

Biotechs benefit more with each successive deal with pharmas.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Biotechnology firms achieve a 23% average increase in market value after completing several partnership deals with pharmaceutical companies. According to research from pharmaceutical intelligence...

Study: Medical liaison staff sizes need expanding.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- A study by Cutting Edge Information identified a trend to expand liaison staffs throughout the industry as more companies recognize the importance of thought leaders' involvement in pharmaceutical...

New biotech company launched by industry veteran.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Cardinal Health, Inc., (CAH) announced the formation of the Biotechnology and Sterile Life Sciences business. The new business brings together a full complement of existing biotechnology and...

Congress budgets $18 million each for CDC lab, Rocky Flats.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Congress has approved spending $18 million for a new U.S. Centers for Disease Control and Prevention (CDC) lab in Fort Collins, Colorado, a fraction of the amount President Bush had recommended. ...

Biotech company reports 7% increase in 2002 revenue, provides business update.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Genencor International, Inc., (GCOR) reported that, for the full year ended December 31, 2002, total revenues increased by 7% to $350.1 million, compared to $326.0 million in 2001. Product...

Pathology IT company receives $8.9M in venture capital funding.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- AD PathLabs Corporation founder and CEO Charles Madden announced that his company has received nearly $8.9 million in Series C Preferred Stock financing, the first institutional investment in the...

Pharmacogenomics company reports net losses of $5.6M.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Genaissance Pharmaceuticals, Inc., (GNSC) reported its financial results for the fourth quarter and year ended December 31, 2002. For the quarter ended December 31, 2002, revenue was $2.6 million...

Record financial results reported by proteomics company.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- Ciphergen Biosystems, Inc., (CIPH) announced record results for the fourth quarter and full year ended December 31, 2002. For the quarter ended December 31, 2002, total revenue increased 86% to...

MDS Nordion sells Oncology Software Solutions business unit.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- MDS Nordion announced that it is selling its Oncology Software Solutions business unit to Delft Instruments, N.V., a holding company that develops, produces, and distributes instruments, systems, and...

Angiogenesis company to remain listed on NASDAQ.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- EntreMed, Inc., (ENMD), announced that it received a determination from the NASDAQ Listing Qualifications Panel to continue the listing of EntreMed's securities on the NASDAQ National Market. As...

Extension possible for compliance with NASDAQ minimum bid price.
March 10, 2003... 2003 MAR 10 - (NewsRx.com & NewsRx.net) -- CytRx Corporation (CYTR) announced that the NASDAQ Stock Market has proposed a new rule that would extend by up to a year the date by which the company must comply with the $1.00 minimum closing bid...

Data reported on rhATIII at thrombosis, hemostasis meeting.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- GTC Biotherapeutics, Inc., (GTCB) announced that three presentations at the 47th Annual Meeting of the Society of Thrombosis and Haemostasis Research (GTH in German) in Innsbruck, Austria featured...

RLX to integrate ServerBlade and storage management tools.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- RLX Technologies, Inc., announced integration of its Control Tower management tool with FilerView from Network Appliance, Inc., (NTAP). This announcement marks a technology relationship between RLX...

Large animal models should have role in immunological research.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Researchers should consider the relevance of large animal models when conducting immunological studies. "The main advances in immunology have been forged or underpinned by animal experiments....

Studies defining new mechanism for potential cancer therapies reported.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Cyclis Pharmaceuticals, Inc., announced publication of laboratory studies demonstrating that an experimental anticancer agent, beta-lapachone, can selectively kill tumor cells while sparing healthy...

Study on agricultural biotech industry finds rapid maturation and consolidation.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Bio Economic Research Associates (bio-era), a new, independent research and advisory firm providing analysis on issues related to human-induced change to biological systems, issued its first study, an...

Health plan veteran joins leadership of research company.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- A veteran of national health plan market intelligence has joined HealthLeaders, Inc., in a new leadership role at HealthLeaders Research, which provides in-depth data and analysis on health plans...

Lemley, Shanaman appointed to board of directors.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Zevex International, Inc., (ZVXI) announced that John T. Lemley and Richard L. Shanaman have been appointed to the company's board of directors, effective immediately. David J. McNally, chairman...

Agreement aims to enhance drug discovery, development.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Science Factory GmbH announced an agreement with IBM to create a combined data management solution that aims to enhance drug discovery and development. Through the agreement, the companies will...

Fourth quarter earnings grow 32% for pharmaceutical company.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- King Pharmaceuticals, Inc., (KG) announced that net earnings equaled $98.1 million for the fourth quarter ending December 31, 2002, up 32% from $74.1 million in the fourth quarter of 2001, excluding...

Registration statement filed with SEC by drug development company.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Inveresk Research Group, Inc., (IRGI) announced the filing of a registration statement with the U.S. Securities and Exchange Commission covering a proposed public offering of up to 10,350,000 shares of...

Pharma industry will see more franchise deals.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Franchise strategy will be an important driver of future pharma industry consolidation, according to Defined Health, a strategy consultancy to the pharmaceutical, biotech, and healthcare investment...

Need for faster drug development/delivery boosts computational software markets.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Because discovery phase research is highly collaborative, the need to standardize data across shifting environments and safeguard the integrity of studies against high employee turnover is driving the...

Women's health company to merge with osteoporosis company.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Inverness Medical Innovations, Inc., (IMA) and Ostex International, Inc., (OSTX), a developer and marketer of tests based on proprietary technologies for the management of osteoporosis, announced that...

Poll: Majority of physicians oppose smallpox vaccinations.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- As the smallpox vaccination debate heats up over such issues as who should be vaccinated, the safety of the vaccine, and associated liability concerns, a study conducted by ePocrates, a handheld...

Japanese biotech establishes U.S. antibody business.
March 17, 2003... 2003 MAR 17 - (NewsRx.com & NewsRx.net) -- Kyowa Hakko Kogyo Co., Ltd., a leading Japanese biotechnology and pharmaceutical company, announced that it has established BioWa, Inc., in the U.S. to pursue development and commercialization of its...

Sierra Pacific Research discovers new anthrax-killing agent.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Sierra Pacific Research Co., a chemical research company specializing in nanosilicate crystallization technology, announced preliminary lab results indicating its patent-pending spray-on solution of...

European ophthalmologists hear about data from trials of OptiVision.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- SurgiLight, Inc., (SRGL), a leader in the development of ophthalmic laser systems, reported that an international team of clinician/researchers had completed a series of LAPR courses and demonstrations...

Monoclonal antibody for peanut-induced anaphylaxis held up in phase III.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- by Richard Hyer, NewsRx correspondent - Sudden death from peanut-induced anaphylaxis is statistically rare, but peanut allergy is less so, affecting approximately 1.5 million people in the U.S. in...

Workforce focused on key research and development programs.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Genelabs Technologies, Inc., (GNLB) announced that it is reducing its workforce by approximately 20%, or 20 employees. The company is not making any reductions to its drug development staff...

St. John's Wort oral spray found to reduce withdrawal symptoms.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Micro Laboratories, Inc., (MLAR) announced results of a study performed by Bruce Becker, MD; Beth Bock, PhD; and Rosa Carmona-Barros, MS, of The Centers for Behavioral & Preventive Medicine, The Miriam...

Private sector must do more to fight AIDS, business group says.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Asia could be hit by the same kind of catastrophic AIDS epidemic as Africa, and the world's business sector must help fight the disease, international business leaders said February 28 in Bangkok. ...

Agreement developed for plasma protein purification.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Gradipore and Serologicals Corporation (SERO) announced a development agreement for evaluating the application of Gradipore's Gradiflow separations technology for the isolation of plasma proteins...

MorphoSys enters therapeutic antibody collaboration, acquires license to ICAM-1.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- MorphoSys, AG, (MOR) and Boehringer Ingelheim have entered a therapeutic antibody collaboration and cross-license agreement. Under the terms of the agreement, MorphoSys receives an exclusive,...

Revenues decrease 17% for provider.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Healthsouth Corporation (HRC) announced operating results for the quarter and year ended December 31, 2002. For the quarter, Healthsouth's revenues were $923.5 million, a decrease of 17.2% as...

Prediction: Diagnostic imaging sales will top $15 billion in sales in 2003.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Medical imaging technology is firmly established as an integral part of modern healthcare, demonstrated by the fact that in 2001 more than a billion medical imaging procedures were performed worldwide,...

Securities purchasers represented in class action lawsuit.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- A lawsuit seeking class action status has been filed in the United States District Court for the District of New Jersey on behalf of all persons who purchased or otherwise acquired the publicly traded...

Biotech slips again in February as war preparations intensify.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- "With the nation on the brink of war and the capital markets held hostage to the concerns surrounding the invasion and the aftermath, investors remained stand-offish in February... and even though...

Emerging anti-obesity drugs estimated to generate $510M by 2008.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Front Line Strategic Consulting, Inc., announced the completion of its new Strategic Market Report, "Emerging Anti-Obesity Therapeutics." Front Line's report includes an in-depth analysis of...

New biotech website announced.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- BiotechWatch LLC announced the launch of its new corporate website. The redesigned site provides access to BiotechWatch's fully searchable databases as well as the ability to purchase its company...

Pharmaceutical companies increase market research resources.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Pharmaceutical brand teams spend between $2 billion and $12 billion per product on market research activities to support launch initiatives, according to a new report by pharmaceutical intelligence...

Promising botulinum toxin markets in the United States attract new participants.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Off-label sales of botulinum toxin, already a major revenue driver for this market, are expected to significantly increase in under-treated disease states such as pain management, spasticity, and focal...

Strategic Answers signs first subscriber for OncoAnswers.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- Strategic Answers, Inc., (SAI) announced that it has secured its first contract for the new OncoAnswers strategic planning tool. QLT, Inc., a global biopharmaceutical company, is the first company...

Company requests investigation by Commission des Operations de Bourse.
March 24, 2003... 2003 MAR 24 - (NewsRx.com & NewsRx.net) -- NicOx, SA, (NICOX) announced that it has requested an investigation from the French securities commission "Commission des Operations de Bourse" regarding transactions in its stock during the weeks...

Testosterone product to be commercialized.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Columbia Laboratories, Inc., (COB) and Quintiles Transnational Corp. (QTRN) announced an agreement to commercialize Columbia's Striant testosterone buccal bioadhesive product in the United States. ...

Argatroban meets primary endpoints in phase II study.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Texas Biotechnology Corporation (TXBI) and GlaxoSmithKline (GSK) announced the results of ARGIS-I, a phase II multicenter clinical trial designed to assess the safety of the direct thrombin inhibitor...

SealChip is focus of three sessions at scientific meeting.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Aviva Biosciences Corporation announced that its planar patch-clamp biochip, SealChip, was the subject of three scientific presentations at the 47th Annual Meeting of the Biophysical Society, held in...

Product, pipeline update provided by cancer drug maker.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Celgene Corporation (CELG) provided an overview of recent developments, including highlights from its extensive research and development pipeline, at the company's analyst and investor meeting in New...

Two new LabChip devices introduced for drug discovery screening.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Caliper Technologies Corp. (CALP) announced the launch of two new microfluidic LabChip devices for use with the Caliper 250 drug discovery system. The 12-sipper Off-Chip Mobility Shift chip will...

Interim data to be presented on phase IIb study in HIV/AIDS.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Hemispherx Biopharma, Inc., (HEB) announced that the company will be giving an oral presentation of its new interim clinical data regarding its phase IIb Trial for HIV/AIDS (labeled Structured...

FDA clearance granted for new chest pain screen.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Biosite Incorporated (BSTE), a leading provider of novel, rapid medical diagnostics, has received clearance from the U.S. Food and Drug Administration (FDA) to market the Triage Cardio ProfilER as an...

Antinausea drug will likely get approval in U.S.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Merck and Co.'s experimental treatment for preventing nausea and vomiting in chemotherapy patients won key support from a group of government advisers, meaning the drug will likely be approved for sale...

Medical journal editorial dubs Gleevec "gold standard".
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Gleevec is the new "gold standard" for treatment of chronic myeloid leukemia (CML), according to an editorial published in a leading medical journal. The editorial cites a study published in the...

Case study challenge expands to foster skills development.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- The second annual Pharmahorizons Case Study Challenge professional development program for the life sciences was launched with the announcement by company president, Stephen Gregory, that the 2003...

Agreement provides ability to use Captisol for early development.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- CyDex, Inc., an innovator in drug delivery technologies, announced an agreement regarding its advanced formulation system Captisol. The Agreement provides Merck the ability to utilize Captisol in...

FDA issues follow-up statement on unapproved long-acting Guaifenesin.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Adams Laboratories, Inc., commented on the U.S. Food and Drug Administration's (FDA) follow-up statement to the agency's October 2002 warning letter for manufacturers and distributors of unapproved...

Biotech company loses $997,000 in 2002.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- AspenBio, Inc., (APNB) announced its preliminary 2002 results. On revenue of $753,000 the company lost $997,000 for the calendar year 2002, as compared to revenues of $1,123,000 and income of...

Biotech secures $3M line of credit for facility growth.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Agensys, Inc., announced it secured a $3 million line of credit from Silicon Valley Bank, a subsidiary of Silicon Valley Bancshares (SIVB). The credit facility will fund equipment purchases and the...

Pharmaceutical company reports quarterly net loss of $1.18 per common share.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Alexion Pharmaceuticals, Inc., (ALXN) announced financial results for its second fiscal quarter and first half ended January 31, 2003. In its second quarter ended January 31, 2003, Alexion reported...

Generic formulation of diabetes drug produced.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- Amarin Corporation plc (AMRN) confirmed that its Swedish subsidiary, Amarin Development AB, has developed a generic formulation of glipizide extended release tablets, as part of an agreement with...

UV absorber suppliers look to Asia for long-term market growth.
March 31, 2003... 2003 MAR 31 - (NewsRx.com & NewsRx.net) -- While the U.S. and Western European markets for UV absorbers in personal care applications still account for upward of 80% of the worldwide total, these markets are relatively mature. With growth...